Literature DB >> 26518135

Magnetic resonance correlation of iron content with neuromelanin in the substantia nigra of early-stage Parkinson's disease.

S Reimão1,2, S Ferreira3, R G Nunes3, P Pita Lobo2,4,5, D Neutel2,4, D Abreu2, N Gonçalves2, J Campos1, J J Ferreira2,4,5,6.   

Abstract

BACKGROUND AND
PURPOSE: Magnetic resonance (MR) studies have demonstrated a significant reduction of neuromelanin in the substantia nigra (SN) of Parkinson's disease (PD) patients with high accuracy for differential diagnosis compared to non-PD controls and essential tremor. However, studies state that not knowing how paramagnetic effects of iron influence neuromelanin signal is a limitation. In this study a neuromelanin-sensitive MR sequence was combined with T2* relaxometry iron quantification analysis to study the SN of early-stage PD patients to investigate the correlation between these parameters.
METHODS: The inclusion criteria were untreated de novo PD patients and a 2-5 year disease duration (early PD); in addition, age-matched controls were enrolled. These were studied at 3.0 T with a high-resolution T1-weighted MR sequence to visualize neuromelanin and a relaxometry sequence for iron quantification. The primary outcome was the correlation of the width of the neuromelanin high signal region and the T2* values in the lateral, central and medial segments of the SN.
RESULTS: Very weak correlations of T2* values with neuromelanin width, positive for global and negative for the medial and lateral SN segments, were found in both PD groups and control subjects. The SN neuromelanin width was markedly reduced in the de novo and early PD groups compared with controls in all SN segments, but no significant difference in T2* values was found between the groups.
CONCLUSIONS: The SN neuromelanin signal does not have a significant correlation with iron content in PD patients or controls. The neuromelanin MR signal reduction in PD does not seem to be significantly influenced by paramagnetic iron effects.
© 2015 EAN.

Entities:  

Keywords:  MRI; Parkinson's disease; iron; neuromelanin; substantia nigra

Mesh:

Substances:

Year:  2015        PMID: 26518135     DOI: 10.1111/ene.12838

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  19 in total

1.  Ventral posterior substantia nigra iron increases over 3 years in Parkinson's disease.

Authors:  Niels Bergsland; Robert Zivadinov; Ferdinand Schweser; Jesper Hagemeier; David Lichter; Thomas Guttuso
Journal:  Mov Disord       Date:  2019-06-10       Impact factor: 10.338

Review 2.  Neuromelanin in Parkinson's Disease: from Fenton Reaction to Calcium Signaling.

Authors:  Rainer Knörle
Journal:  Neurotox Res       Date:  2017-09-06       Impact factor: 3.911

Review 3.  [Helpful instrumental examinations in idiopathic Parkinson's disease].

Authors:  U Walter; H Zach; I Liepelt-Scarfone; W Maetzler
Journal:  Nervenarzt       Date:  2017-04       Impact factor: 1.214

4.  Quantifying changes in nigrosomes using quantitative susceptibility mapping and neuromelanin imaging for the diagnosis of early-stage Parkinson's disease.

Authors:  Hiroto Takahashi; Yoshiyuki Watanabe; Hisashi Tanaka; Masahito Mihara; Hideki Mochizuki; Tian Liu; Yi Wang; Noriyuki Tomiyama
Journal:  Br J Radiol       Date:  2018-05-17       Impact factor: 3.039

Review 5.  Magnetic resonance imaging for the diagnosis of Parkinson's disease.

Authors:  Beatrice Heim; Florian Krismer; Roberto De Marzi; Klaus Seppi
Journal:  J Neural Transm (Vienna)       Date:  2017-04-04       Impact factor: 3.575

Review 6.  Iron metabolism and its detection through MRI in parkinsonian disorders: a systematic review.

Authors:  Sara Pietracupa; Antonio Martin-Bastida; Paola Piccini
Journal:  Neurol Sci       Date:  2017-09-02       Impact factor: 3.307

Review 7.  New Imaging Markers for Movement Disorders.

Authors:  Christine Ghadery; Antonio P Strafella
Journal:  Curr Neurol Neurosci Rep       Date:  2018-04-03       Impact factor: 5.081

8.  The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson's disease.

Authors:  Emma Biondetti; Mathieu D Santin; Romain Valabrègue; Graziella Mangone; Rahul Gaurav; Nadya Pyatigorskaya; Matthew Hutchison; Lydia Yahia-Cherif; Nicolas Villain; Marie-Odile Habert; Isabelle Arnulf; Smaranda Leu-Semenescu; Pauline Dodet; Miquel Vila; Jean-Christophe Corvol; Marie Vidailhet; Stéphane Lehéricy
Journal:  Brain       Date:  2021-11-29       Impact factor: 13.501

Review 9.  Nigrosome Imaging and Neuromelanin Sensitive MRI in Diagnostic Evaluation of Parkinsonism.

Authors:  Nicola Pavese; Yen F Tai
Journal:  Mov Disord Clin Pract       Date:  2018-02-22

10.  Evaluation of the Swallow-Tail Sign and Correlations of Neuromelanin Signal with Susceptibility and Relaxations.

Authors:  Tzu-Wei Lee; Cheng-Yu Chen; Kuan Chen; Chao-Wei Tso; Hui-Hsien Lin; Ying-Liang Larry Lai; Fei-Ting Hsu; Hsiao-Wen Chung; Hua-Shan Liu
Journal:  Tomography       Date:  2021-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.